These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 31270617)

  • 1. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
    Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG
    Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
    Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E
    J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
    Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
    Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
    Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
    Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
    Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
    Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
    Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
    Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study.
    Amin O; Prestel C; Gonzalez MD; Lyon T; Shane A; Jaggi P; Tippett A; Yildirim I
    Pediatr Infect Dis J; 2020 Mar; 39(3):211-216. PubMed ID: 32032306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Extended-Spectrum β-Lactamase-Producing Pathogens in Community-Acquired Urinary Tract Infections Among Infants at a Pediatric Emergency Department.
    Tamas V; Shah S; Hollenbach KA; Kanegaye JT
    Pediatr Emerg Care; 2022 Mar; 38(3):e1053-e1057. PubMed ID: 35226630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study.
    Dotis J; Printza N; Marneri A; Gidaris D; Papachristou F
    Turk J Pediatr; 2013; 55(6):571-4. PubMed ID: 24577973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
    Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
    Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
    Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
    J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative urinary tract infections and increasing isolation of ESBL-producing or ceftazidime-resistant strains in children: results from a single-centre survey.
    Giardino S; Bandettini R; Perotti M; Piaggio G; Degl'Innocenti L; Sacco R; Ciucci A; Caviglia I; Barabino P; Ginocchio F; Losurdo G; Haupt R; Castagnola E
    Infez Med; 2013 Mar; 21(1):29-33. PubMed ID: 23524898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
    Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.